Approval · Notice of Compliance 1507 · 2000
VALSTAR: Notice of Compliance 1507
Issued July 4, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1507
- Date
- July 4, 2000
- Company
- Anthra Pharmaceuticals, Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Cytotoxic antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VALSTAR | 02242466 | Cancelled Post Market |
Medicinal ingredients
- VALRUBICIN 40 MG per ML